Ficonalkib

N/A

Report date: 2025/11/06 15:39:24
NME

Base Information

Drug NameFiconalkib
Drug Alias NameCT-3505SY-3505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnaplastic lymphoma kinase inhibitorsFocal adhesion kinase 1 inhibitorsFocal adhesion kinase 2 inhibitors +[4] 
TargetsAnaplastic lymphoma kinaseFocal adhesion kinase 1Focal adhesion kinase 2 +[4] 
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShouyao Holding (Beijing) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShouyao Holding (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A